Unknown

Dataset Information

0

Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia.


ABSTRACT: OBJECTIVE:Attaining glycemic targets without severe hypoglycemic events (SHEs) is a challenging treatment goal for patients with type 1 diabetes complicated by impaired awareness of hypoglycemia (IAH). The CIT Consortium Protocol 07 (CIT-07) trial showed islet transplantation to be an effective treatment for subjects with IAH and intractable SHEs. We evaluated health-related quality of life (HRQOL), functional health status, and health utility before and after pancreatic islet transplantation in CIT-07 trial participants. RESEARCH DESIGN AND METHODS:Four surveys, the Diabetes Distress Scale (DDS), the Hypoglycemic Fear Survey (HFS), the Short Form 36 Health Survey (SF-36), and the EuroQoL 5 Dimensions (EQ-5D), were administered repeatedly before and after islet transplantation. Summary statistics and longitudinal modeling were used to describe changes in survey scores from baseline and to characterize change in relation to a minimally important difference (MID) threshold of half an SD. RESULTS:Improvements in condition-specific HRQOL met the MID threshold. Reductions from baseline in the DDS total score and its four DDS subscales (all P ? 0.0013) and in the HFS total score and its two subscales (all P < 0.0001) were observed across all time points. Improvements were observed after both 1 and 2 years for the EQ-5D visual analog scale (both P < 0.0001). CONCLUSIONS:In CIT-07, 87.5% of the subjects achieved the primary end point of freedom from SHE along with glycemic control (HbA1c <7% [<53 mmol/mol]) at 1 year post-initial islet transplantation. The same subjects reported consistent, statistically significant, and clinically meaningful improvements in condition-specific HRQOL as well as self-assessments of overall health.

SUBMITTER: Foster ED 

PROVIDER: S-EPMC5911786 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improved Health-Related Quality of Life in a Phase 3 Islet Transplantation Trial in Type 1 Diabetes Complicated by Severe Hypoglycemia.

Foster Eric D ED   Bridges Nancy D ND   Feurer Irene D ID   Eggerman Thomas L TL   Hunsicker Lawrence G LG   Alejandro Rodolfo R  

Diabetes care 20180321 5


<h4>Objective</h4>Attaining glycemic targets without severe hypoglycemic events (SHEs) is a challenging treatment goal for patients with type 1 diabetes complicated by impaired awareness of hypoglycemia (IAH). The CIT Consortium Protocol 07 (CIT-07) trial showed islet transplantation to be an effective treatment for subjects with IAH and intractable SHEs. We evaluated health-related quality of life (HRQOL), functional health status, and health utility before and after pancreatic islet transplant  ...[more]

Similar Datasets

| S-EPMC5317236 | biostudies-literature
| S-EPMC1119303 | biostudies-literature
| S-EPMC10585599 | biostudies-literature
| S-EPMC7731068 | biostudies-literature
| S-EPMC6854960 | biostudies-literature
| S-EPMC5380118 | biostudies-literature
| S-EPMC9845885 | biostudies-literature
| S-EPMC5869577 | biostudies-literature
| S-EPMC2933074 | biostudies-literature
| S-EPMC6015781 | biostudies-literature